In acute promyelocytic leukemia, it targets promyelocytic leukemia protein (PML) for degradation of the oncogenic fusion protein PML-RARα resulted from the (15;17) gene translocation [4]. This evidence concerns the gene PML and acute promyelocytic leukemia.